CRL > Insurance > Stay Informed

Stay Informed

To register for CRL's "Reference Point" newsletter: Click Here

12/11 Reference Point

09/11 Reference Point

06/11 Reference Point

12/10 Reference Point

07/10 Reference Point

02/10 Reference Point

11/09 Reference Point

08/09 Reference Point

Press Release:

Aplifi & CRL Align to Deliver Electronic Lab Results

 

CRL's published Research & Development:

HbA1c values from 5 to 7% and mortality*

HbA1c more lives with added detail

Albumin and all-cause mortality*

Serum alcohol and CDT (heavy use marker) and mortality*

Bilirubin levels and mortality 

CEA screening of "healthy" adults and mortality*

CEA lives and details

Lipid tests and ratios as mortality predictors*

Cocaine the real risk

Smoking (urine continine levels) and mortality risk

Glucosurina and mortality risk

Liver enzymes in a very large "healthy" cohort (ALT, AST, GGT & AP and mortality*

Non-cig tobacco use and mortality

                                                                     *-peer reviewed medical journal article

 

 

CRL is a registered trademark of Clinical Reference Laboratory, Inc.